Filter
1359
Text search:
World
Health
Organization
Americas
Featured
Recommendations
163
New Publications
293
Language
Document type
No document type
543
Studies & Reports
349
Guidelines
215
Manuals
84
Strategic & Response Plan
69
Fact sheets
33
Training Material
22
Situation Updates
18
Resource Platforms
15
Infographics
5
Brochures
2
Online Courses
2
App
1
Countries / Regions
Latin America and the Carribbean
158
Global
118
Brazil
29
North America
17
Colombia
16
Venezuela
14
Africa
13
Haiti
12
India
12
South–East Asia Region
10
Asia
10
Syria
9
Western and Central Europe
9
Paraguay
9
South Africa
8
Sierra Leone
7
Nigeria
7
Congo, Democratic Republic of
7
Liberia
6
Uganda
6
South Sudan
6
Afghanistan
6
Kenya
6
Peru
6
Middle East and North Africa
6
Nepal
5
Pakistan
5
Cambodia
5
China
5
Bangladesh
5
Madagascar
5
Chile
5
Ghana
4
Zimbabwe
4
Indonesia
4
Ecuador
4
Yemen
4
East and Southern Africa
4
Eastern Europe
4
Guinea
3
Ethiopia
3
Philippines
3
Somalia
3
Iraq
3
Thailand
3
Rwanda
3
Argentina
3
Namibia
3
Honduras
3
El Salvador
3
Bolivia
3
Mexico
3
Myanmar / Burma
3
West and Central Africa
3
Western Pacific Region
3
Russia
3
Iran
3
Senegal
2
USA
2
Lebanon
2
Tanzania
2
Malawi
2
Mozambique
2
Sudan
2
Burkina Faso
1
Morocco
1
Saudi Arabia
1
Niger
1
Jordan
1
Turkey
1
Egypt
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Vanuatu
1
Dominican Republic
1
Serbia
1
Ukraine
1
Greece
1
Guatemala
1
Cape Verde
1
Lesotho
1
Nicaragua
1
Eastern Europe and Central Asia
1
Other region
1
Solomon Islands
1
Palestine
1
North Korea
1
Albania
1
Mongolia
1
Laos
1
Canada
1
Estonia
1
Moldova
1
Georgia
1
Vietnam
1
Tunisia
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
235
Clinical Guidelines
174
Public Health
124
Women & Child Health
89
Key Resources
68
Capacity Building
25
Pharmacy & Technologies
14
Annual Report MEDBOX
1
Toolboxes
Mental Health
141
COVID-19
134
NTDs
107
HIV
105
Zika
93
TB
68
Planetary Health
53
NCDs
50
Rapid Response
40
Global Health Education
40
Malaria
39
Disability
35
Caregiver
31
AMR
29
2.0 Rapid Response
25
Pharmacy
22
Refugee
20
Ebola & Marburg
16
Conflict
13
Health Financing Toolbox
13
Cholera
12
Natural Hazards
12
Polio
11
Social Ethics
4
Specific Hazards
3
Typhoon
1
Building laboratory testing capacity
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho
...
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also di
...
The objectives of this guideline are the same as those of the 2011 edition, namely to provide evidence-based normative guidance on interventions to improve adolescent morbidity and mortality by reducing the chances of early pregnancy and its resulting poor
...
This document is for public health specialists, health emergency responders, clinicians, health facility managers,
...
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance.
...
Pillar 3 of the Global technical strategy for malaria 2016–2030 calls for the transformation of malaria surveillance into a core intervention in all malaria-endemic countries, as well as in countries which have eliminated malaria but remain susceptible to re-establishment of transmission. This ref
...
Preferred product characteristics and clinical development considerations
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN
...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
This global guidance was developed to support malaria-free countries and those that are close to malaria elimination to prevent re-establishment. The document outlines key concepts and principles for preventing re-establishment and provides guidance on strategies, interventions, planning and managem
...
This publication provides guidance for planning country-specific programming to achieve the triple elimination of mother-to-child (or vertical) transmission of HIV, syphilis and hepatitis B virus. It is based on the WHO Triple Elimination Framework, which promotes an integrated, person-centred appro
...
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages
...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
This guidance synthesizes current evidence on dengue laboratory testing and diagnostics and provides practical recommendations for laboratories, clinicians, public health officials, and programme managers involved in dengue diagnosis, surveillance,
...
Drawing on the World Health Organization’s package of NCD best buys, the report demonstrates how these evidence-based measures can help countries
...
The global cholera statistics for 2024, showing an increase in both the number of people who fell sick and died from the disease.
Reported cholera cases rose by 5% and deaths by 50% in 2024 compared to 2023, with more than 6000 people dying from a disease that is both preventable and treatable. Whi
...
WHO consolidated guidelines on tuberculosis: Module 6: tuberculosis and comorbidities, 2nd ed
recommended
Addressing TB comorbidities and risk factors is central to the World Health Organization (WHO) End TB Strategy. These guidelines consolidate the la
...
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment.
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current lands
...
